v3.24.3
Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock Series A [Member]
Preferred Stock Series A 1 A 2 A 3 A 4 [Member]
Preferred Stock Series B B 1 [Member]
Preferred Stock Series B 2 B 3 [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 0 $ 0 $ 0 $ 0 $ 5 $ 41,596,106 $ (39,370,153) $ 2,225,958
Beginning balance, shares at Dec. 31, 2022 0 0 0 0 491,345      
Share-based compensation 82,531 82,531
Proceeds from sale of Series A preferred stock $ 1,000 1,000
Proceeds from sale of Series A preferred stock, shares 1              
Redemption of Series A Preferred stock $ (1,000) (1,000)
Redemption of Series A Preferred stock, shares (1)              
Net income (loss) (1,183,460) (1,183,460)
Ending balance, value at Mar. 31, 2023 $ 0 $ 0 $ 0 $ 0 $ 5 41,678,637 (40,553,613) 1,125,029
Ending balance, shares at Mar. 31, 2023 0 0 0 0 491,345      
Beginning balance, value at Dec. 31, 2022 $ 0 $ 0 $ 0 $ 0 $ 5 41,596,106 (39,370,153) 2,225,958
Beginning balance, shares at Dec. 31, 2022 0 0 0 0 491,345      
Net income (loss)               (2,648,017)
Ending balance, value at Jun. 30, 2023 $ 0 $ 0 $ 0 $ 0 $ 5 42,028,387 (42,018,169) 10,223
Ending balance, shares at Jun. 30, 2023 0 0 0 0 512,555      
Beginning balance, value at Mar. 31, 2023 $ 0 $ 0 $ 0 $ 0 $ 5 41,678,637 (40,553,613) 1,125,029
Beginning balance, shares at Mar. 31, 2023 0 0 0 0 491,345      
Share-based compensation 136,631 136,631
Commitment shares - note financing 175,619 175,619
Commitment shares - note financing, shares       21,210      
Issuance of warrants - note financing 37,500 37,500
Net income (loss) (1,464,557) (1,464,557)
Ending balance, value at Jun. 30, 2023 $ 0 $ 0 $ 0 $ 0 $ 5 42,028,387 (42,018,169) 10,223
Ending balance, shares at Jun. 30, 2023 0 0 0 0 512,555      
Beginning balance, value at Dec. 31, 2023 $ 0 $ 0 $ 0 $ 0 $ 8 43,553,524 (44,281,526) (727,995)
Beginning balance, shares at Dec. 31, 2023 0 0 0 0 825,459      
Share-based compensation 85,827 85,827
Issuance of common shares related to restricted stock units
Issuance of common shares related to restricted stock units, shares       4,261      
Issuance of common shares - equity line of credit $ 5 1,449,527 1,449,532
Issuance of common shares - equity line of credit, shares       452,343      
Issuance of commitment shares - note financing 33,297 33,297
Issuance of commitment shares - note financing, shares       9,312      
Cashless exercise of pre-funded warrants
Cashless exercise of pre-funded warrants, shares       2,915      
Issuance of common stock and warrants related to public offering, net issuance costs $ 52 2,691,339 2,691,391
Issuance of common stock and warrants related to public offering, net issuance costs, shares       5,175,000      
Public offering and line of credit issuance costs (399,106) (399,106)
Issuance of common shares - debt for equity exchange $ 6 1,771,600 1,771,606
Issuance of common shares - debt for equity exchange, shares       644,142      
Round up conversion related to reverse stock split
Round up convention related to reverse stock split, shares       40,068      
Net income (loss) (2,399,102) (2,399,102)
Ending balance, value at Mar. 31, 2024 $ 0 $ 0 $ 0 $ 0 $ 72 49,186,006 (46,680,628) 2,505,449
Ending balance, shares at Mar. 31, 2024 0 0 0 0 7,153,500      
Beginning balance, value at Dec. 31, 2023 $ 0 $ 0 $ 0 $ 0 $ 8 43,553,524 (44,281,526) (727,995)
Beginning balance, shares at Dec. 31, 2023 0 0 0 0 825,459      
Net income (loss)               (3,637,180)
Ending balance, value at Jun. 30, 2024 $ 0 $ 0 $ 0 $ 0 $ 82 49,560,800 (47,918,705) 1,642,177
Ending balance, shares at Jun. 30, 2024 0 0 0 0 8,210,671      
Beginning balance, value at Mar. 31, 2024 $ 0 $ 0 $ 0 $ 0 $ 72 49,186,006 (46,680,628) 2,505,449
Beginning balance, shares at Mar. 31, 2024 0 0 0 0 7,153,500      
Share-based compensation 70,305 70,305
Issuance of common shares related to restricted stock units
Issuance of common shares related to restricted stock units, shares         7,171      
Issuance of common shares - equity line of credit $ 10 304,490 304,500
Issuance of common shares - equity line of credit, shares         1,050,000      
Net income (loss) (1,238,077) (1,238,077)
Ending balance, value at Jun. 30, 2024 $ 0 $ 0 $ 0 $ 0 $ 82 $ 49,560,800 $ (47,918,705) $ 1,642,177
Ending balance, shares at Jun. 30, 2024 0 0 0 0 8,210,671